Evidence map›Paper›PMID 39826490›Full record

ArticleParkinsonism & related disorders2025

Longitudinal assessment of white matter alterations in progressive supranuclear palsy variants using diffusion tractography.

Francesco Costa, Rodolfo G Gatto, Nha Trang Thu Pham, Farwa Ali, Heather M Clark, Julie Stierwalt, Mary M Machulda, Federica Agosta, Massimo Filippi, Keith A Josephs and 1 more

Abstract read
In one paragraph

Article in Parkinsonism & related disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Tongue strength in progressive supranuclear palsy.Parkinsonism & related disorders · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Francesco CostaDepartment of Radiology, Mayo Clinic, Rochester, MN, USA; Vita-Salute San Raffaele University, Milan, Italy.
Rodolfo G GattoDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Nha Trang Thu PhamDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.
Farwa AliDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Heather M ClarkDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Julie StierwaltDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Mary M MachuldaDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Federica AgostaVita-Salute San Raffaele University, Milan, Italy; Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Neurology and Neurophysiology Units, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Massimo FilippiVita-Salute San Raffaele University, Milan, Italy; Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Neurology and Neurophysiology Units, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Keith A JosephsDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Jennifer L WhitwellDepartment of Radiology, Mayo Clinic, Rochester, MN, USA. Electronic address: Whitwell.jennifer@mayo.edu.

Funding

Longitudinal multi-modality imaging in progressive apraxia of speech (Diversity Supplement)R01DC012519 · NIDCD · MAYO CLINIC ROCHESTER · PI Jennifer Louise Whitwell · 2013 to 2026
$7.2M
Longitudinal Multi-modal Imaging in Progressive Supranuclear Palsy SyndromesR01NS089757 · NINDS · MAYO CLINIC ROCHESTER · PI JOSEPHS, KEITH A, WHITWELL, JENNIFER LOUISE · 2015 to 2024
$5.6M
NIDCD NIH HHS R01 DC012519NINDS NIH HHS R01 NS089757
6 · The paper itself

Abstract

introductionWhite matter (WM) tract degeneration is a characteristic feature of progressive supranuclear palsy (PSP), with longitudinal changes observed in PSP-Richardson's syndrome (PSP-RS). Little, however, is known about the other PSP variants. We assessed cross-sectional and longitudinal WM degeneration across PSP variants using diffusion tractography.

methodsForty-eight PSP patients were recruited by the Neurodegenerative Research Group, Mayo Clinic, and underwent two diffusion MRI, 1-year apart. We measured fractional anisotropy and mean diffusivity from eight WM tracts reconstructed using deterministic tractography. Baseline and rates of change were compared across PSP variants grouped into PSP-RS, PSP-cortical, and PSP-subcortical, and correlated with clinical disease severity.

resultsPSP-RS, PSP-cortical and PSP-subcortical showed overlapping but distinct baseline patterns of WM alterations. Longitudinally, faster rates of degeneration were observed in the superior cerebellar peduncle (SCP) and dentatorubrothalamic tract (DRTT) in all groups compared to controls. In PSP-RS, the anterior thalamic radiation also showed faster rates of degeneration compared to controls. PSP-cortical had faster rates of degeneration in many WM tracts compared to controls and other PSP groups, including body of corpus callosum, superior thalamic radiation, superior corticostriatal tract, superior longitudinal fasciculus, and frontal aslant tract. Progression in the PSP-subcortical group was limited to SCP and DRTT. Greater rates of degeneration in the corpus callosum and SCP correlated with worsening disease severity.

conclusionsDifferent progression patterns of WM degeneration characterize the PSP variants, although degeneration of the SCP is a common feature and could be a useful potential biomarker for clinical treatment trials in PSP.

Indexed as

Diffusion Tensor ImagingSupranuclear Palsy, ProgressiveWhite MatterAgedCross-Sectional StudiesDisease ProgressionFemaleHumansLongitudinal StudiesMaleMiddle AgedDiffusion tractographyDTIProgressive supranuclear palsy (PSP) variantsRichardson's syndromeWhite matter progression

Identifiers

PMID39826490
PMCPMC11854829

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.